Cleveland Clinic Appoints Jame Abraham, M.D., F.A.C.P., as Department Chair of Hematology/Medical Oncology

Media Contact

Katrina Healy 216-386-0955

Ellie Westerburg 216.312.4755

Jame Abraham, M.D.

Jame Abraham, M.D., F.A.C.P., has been appointed the new chair of the Hematology/Medical Oncology Department at Cleveland Clinic. In this capacity, he will recruit and develop staff, and guide the department’s focus on patient access and a multidisciplinary approach to care.

Dr. Abraham currently serves as the director of the Breast Oncology Program at Taussig Cancer Institute and co-director of the Cleveland Clinic Comprehensive Breast Cancer Program. He is also a professor of medicine at Cleveland Clinic Lerner College of Medicine.

Dr. Abraham is a member of the National Comprehensive Cancer Network (NCCN) Breast Cancer Committee, vice chair of the Research Strategy Committee of NRG Oncology, and a member of the Breast Cancer Working Committee for NRG Oncology. He is the vice chair of the Research Review Committee for the National Surgical Adjuvant Breast and Bowel Project (NSABP).

As the national principal investigator of multiple breast cancer clinical trials, Dr. Abraham has published and presented more than 200 papers. He is also the founding editor of the Bethesda Handbook of Oncology (Wolter Kluwer).

“Successfully leading our Hematology/Medical Oncology Department requires a leader who excels at empathy, fosters a culture of teamwork, demonstrates emotional intelligence and believes in the vision of our institute,” said Brian Bolwell, M.D., chairman of Taussig Cancer Institute. “Dr. Abraham represents these qualities and has exhibited a passion for department and caregiver development, and elevating our national reputation.”

“I look forward to building upon Cleveland Clinic Taussig Cancer Institute’s position as a leader in hematology and medical oncology, delivering outstanding, compassionate patient care and innovative research,” said Dr. Abraham. “I am honored to serve patients who choose Cleveland Clinic for advanced cancer treatment and to support the department’s committed and passionate caregivers.”

He completed his residency at the University Of Connecticut School Of Medicine, followed by a medical oncology fellowship from the National Cancer Institute (NCI) and hematology fellowship from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. He earned his medical degree from Calicut Medical College in Kerala, India.

As department chair, Dr. Abraham succeeds Cleveland Clinic hematologist Matt Kalaycio, M.D.

About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. Among Cleveland Clinic’s 67,554 employees worldwide are more than 4,520 salaried physicians and researchers, and 17,000 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,026-bed health system that includes a 165-acre main campus near downtown Cleveland, 18 hospitals, more than 220 outpatient facilities, and locations in southeast Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2019, there were 9.8 million total outpatient visits, 309,000 hospital admissions and observations, and 255,000 surgical cases throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 185 countries. Visit us at Follow us at and News and resources available at